Cord blood T regulatory cells synergize with ruxolitinib to improve GVHD outcomes
UCB Treg+Ruxolitinib combination improves outcomes in xenogeneic GVHD and should be explored in a clinical setting.
Authors
- Simrit Parmar (ORCID: https://orcid.org/0000-0003-1798-9233)
- Hongbing Ma (ORCID: https://orcid.org/0000-0002-1174-4078)
- Christopher R. Flowers (ORCID: https://orcid.org/0000-0002-9524-3990)
- Meixian Huang (ORCID: https://orcid.org/0000-0002-6245-9365)
- Mi-Ae Lyu
- Ke Zeng (ORCID: https://orcid.org/0000-0002-4398-3612)
- Tara Sadeghi
Institutions
- The University of Texas MD Anderson Cancer Center (US)
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
- Texas A&M University (US)
Publication Details
- Journal
- Frontiers in Transplantation
- Published
- 2024-12-11
- DOI
- https://doi.org/10.3389/frtra.2024.1448650
- Citations
- 2
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.91